PPT-Stratifying stroke risk to guide antithrombotic therapy in patients with AF

No evidence that AF type significantly impacts stroke risk Scandinavian followup study of patients treated for paroxysmal n855 and permanent AF n1126 during 2002 mean followup 36 years Aim to investigate differences in stroke risk in the two cohorts. Ron Pellegrino, MD. November 20, 2015. Objectives. Become comfortable with risk factor modification and chronic management of the post stroke patient.. Review the major modifiable risk factors. HTN guidelines for long term management of ischemic stroke. thrombotics. in patients undergoing GI endoscopy. Dr Osman . Mapkar. Gastroenterolgy. Unit . Jahra. Hospital. Antithrombotic therapy. Indications. AF. ACS. DVT. Hypercoagulable states. Endoprostheses. Important Considerations . as TAVR Moves to . Lower-Risk Patients. Benjamin Z Galper MD MPH. Brigham & Women’s Hospital Boston MA. Consequences of Stroke. Mortality. – TAVR patients suffering a VARC-2 disabling stroke have significantly higher mortality rates compared to patients without stroke. 1-year mortality of 67% vs. 12% and 2-year mortality of 83% vs. 20%.. Louis Muller. EM Registrar. January 2010. Objectives. Define TIA. Change in Definition.. How is TIA dx?. How should TIA be evaluated in the ED?. How should these patients be treated in ED?. What is their correct disposition?. Assistant Professor. Department of Internal Medicine – Hospital Medicine Division. Medical Director – UNM Anticoagulation Clinic. Co-Director Antithrombotic Stewardship. Roadmap. Direct oral anticoagulants. . Alan Brush, MD, FACP. Chief, Anticoagulation Management Service. Harvard Vanguard Medical Associates. Language. . .. Suggestions . vs. . Recommendations: . based on the weight of evidence. Loading . There are two types of strokes . –. . ischaemic. (clot) and . haemorrhagic. (bleed). . About 85% of all strokes are . ischaemic. and 15% . haemorrhagic. How often does stroke strike?. Occurs 152,00 times a year in the UK . surgery. -. . new . approaches. Assoc. . Prof. Tatjana Šimurina MD, . PhD. General . Hospital Zadar; Dept. of Health Study, University of Zadar; . Medical . faculty, University of Osijek . tsimurina@unizd.h. Assoc. iate. . . Prof Tatjana Šimurina MD, PhD. General Hospital Zadar; . Dept. .. . of Health Study, University of Zadar; . Assist Prof - Medical faculty, University of Osijek . tsimurina@unizd.hr. Patient back to baseline. Vitals stable. . Sent to OSH where CT head shows old stroke.. Work up at outside including cardiac echo, carotid US negative.. PMH: as above plus two previous episodes of falling. Assist.Lect. . . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals of treatment for acute ischemic stroke include reducing secondary brain damage by re-establishing and maintaining adequate perfusion to marginally ischemic areas of the brain and to protect these areas from the effects of ischemia (i.e., . Medical Director, . Resp. Care. Lodi Memorial Hospital. Assoc. . Clin. Prof Medicine. UC Davis . STROKE. Acute brain disorder of vascular origin accompanied by neurological dysfunction that persists for longer than 24 hours…. OHHI Cardiology Group. Antiplatelet and Anticoagulation Therapy – What You Need to Know. Objectives. Utilize current practice guidelines for the management of antiplatelet therapy in CAD patients.. Current and Future. Published in journal of European neurology. On august 2022. INTRODUCTION. Despite progress in the . understanding of the pathophysiological mechanisms underlying stroke over the past 3 decades, concerning early diagnosis and the development of protocols that have reduced the door-to-needle time for acute ischemic stroke (AIS) treatment, several clinical gaps remain unsolved..